SEC Form EFFECT filed by Haymaker Acquisition Corp. III
$HYAC
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 4, 2023 5:15 P.M. |
| Form: | S-1 | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 4, 2023 5:15 P.M. |
| Form: | S-1 | ||||||
| |||||||
Save time and jump to the most important pieces.
4 - biote Corp. (0001819253) (Issuer)
4 - biote Corp. (0001819253) (Issuer)
4 - biote Corp. (0001819253) (Issuer)
NEW YORK, Sept. 12, 2023 /PRNewswire/ -- Haymaker Acquisition Corp. 4 (NYSE:HYAC) (the "Company") announced today that, commencing September 15, 2023, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the New York Stock Exchange under the symbols "HYAC" and "HYAC WS," respectively. Those units not separated will continue to trade on the New York Stock Exchange under the symbol "HYAC U." This press
Business combination with Haymaker Acquisition Corp. III complete biote Corp.'s common stock will trade on the Nasdaq Stock Exchange under ticker symbol "BTMD" biote Corp., (NASDAQ:BTMD) ("Biote" or the "Company"), a high growth, differentiated medical practice-building business within the hormone optimization space, today announced that it has completed its business combination with Haymaker Acquisition Corp. III (NASDAQ:HYAC) ("Haymaker"), a special purpose acquisition company. The business combination, which was approved by Haymaker's stockholders at its special meeting held on May 24, 2022, as well as the credit facilities entered into in connection with the closing of the business co
NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Haymaker Acquisition Corp. III (NASDAQ:HYAC) ("Haymaker" or the "Company"), a publicly traded special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination (the "Business Combination") with Biote, and the related proposals, at Haymaker's special meeting held on May 24, 2022. A Form 8-K disclosing the full voting results has been filed with the Securities and Exchange Commission. The closing of the Business Combination is anticipated to take place on or about May 26, 2022. Following closing of the Business Combination, the common stock and warrants of the combined comp
10-Q - Haymaker Acquisition Corp. 4 (0001970509) (Filer)
8-K - Haymaker Acquisition Corp. 4 (0001970509) (Filer)
10-Q - Haymaker Acquisition Corp. 4 (0001970509) (Filer)
SC 13G/A - Haymaker Acquisition Corp. 4 (0001970509) (Subject)
SC 13G - Haymaker Acquisition Corp. 4 (0001970509) (Subject)
SC 13G - biote Corp. (0001819253) (Subject)
On Thursday, 94 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Medtronic (NYSE:MDT) was the biggest company on a market cap basis to set a new 52-week low. Performance Shipping (NASDAQ:PSHG) was the smallest company when considering market cap to set a new 52-week low. NRX Pharmaceuticals (NASDAQ:NRXP)'s stock came under the most pressure, trading down 63.34% to reach a new 52-week low. Centogene (NASDAQ:CNTG)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low. Stocks that set new 52-week lows on Thursday are as follows: Medtronic (NYSE:MDT) stock drifted down 4.4% on Thursday morning to hit a new 52-week low o
Haymaker Acquisition Corp. III (NASDAQ:HYAC) ("Haymaker" or the "Company"), a publicly traded special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination (the "Business Combination") with Biote, and the related proposals, at Haymaker's special meeting held on May 24, 2022. A Form 8-K disclosing the full voting results has been filed with the Securities and Exchange Commission. The closing of the Business Combination is anticipated to take place on or about May 26, 2022. Following closing of the Business Combination, the common stock and warrants of the combined company, called "biote Corp.," are expected to comm